Crowdfunding proceeds will be used to finalize first rare disease computer model
We're pleased to announce the launch of our #HackRare crowdfunding campaign on Indiegogo. Our goal is to raise $20,000 (U.S.) to advance rare disease research.
123Genetix has developed a big data solution called DeepNEU to empower rare disease researchers. Using elements of artificial intelligence, DeepNEU can create models of rare disease biology and discover and identify patterns and relationships from complex datasets, and even effectively predict future outcomes. These models are designed to empower medical researchers to discover potential new research directions that may identify disease specific biomarkers that can lead to new and effective treatments for several rare diseases.
The crowdfunding proceeds will accelerate the roll-out of our predictive computer models of rare disease biology. More specifically, the campaign proceeds will be used to finalize the social enterprise’s rare disease model for RETT syndrome and to purchase additional hardware and update software, which would allow us to develop, validate and deploy several disease models at a time. Depending on the amount raised, the proceeds may also be used to begin the software development of a dedicated database for the storage of, and eventual global access to, a growing library of validated rare disease models.
For more information about the #HackRare campaign, visit: http://igg.me/at/hackrare
If you can’t make a donation at this time, we would still appreciate it if you could share our campaign page on your social media accounts or do the old school word of mouth thing and tell your friends. If you do the social media thing, please include our #HackRare hash tag in your post.
The Unmet Need: A rare disease is generally a disease that affects a small percentage of the population. However, rare diseases are more common than you might think. There are more than 7,000 known rare diseases affecting over 300 million people worldwide. That’s almost the size of the population of the United States. In North America, rare diseases affect 8% to 10% of the population. About 80% of rare diseases have a genetic basis and 50% of rare diseases affect children. Unfortunately, less than 50% of known rare diseases have organizations to advocate on behalf of patients and their families. Compounding this ongoing problem is the ever increasing competition for limited and diminishing resources supporting rare diseases research.
About our blog
We intend to use this space to help you get to know 123Genetix, our team and our mission, as well as to create more awareness for rare diseases and the limitations their researchers face.